GL1X · GenesisL1 explorer

Ligand · Q7M

Q7M · 2-amino-1-[4-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl]-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide

Q7M, 2-amino-1-[4-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl]-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide (C25 H18 F3 N7 O2, 505.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
Q7M
Formula
C25 H18 F3 N7 O2
Class
ligand
Structures
2
PDB entries
1

Binding sites

Q7M in 2 structures; the first of them:

  • 4P5Z · Human EphA3 Kinase domain in complex with quinoxaline derivatives · Q7M A1001 · binds VAL627, GLY628, ALA629, VAL635, ALA651, LYS653, GLU670, ILE673 and 16 more
  • 4P5Z · Human EPHA3 kinase domain in complex with quinoxaline derivatives · Q7M A1001 · binds VAL627, GLY628, ALA629, VAL635, ALA651, LYS653, GLU670, ILE673 and 16 more

Residues it binds most

ILE 2, VAL 2, ALA 2, GLU 2, LEU 2, MET 2, PHE 2, TYR 2, ASP 2, GLY 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.